Healthcare ❯ Pharmaceuticals

Diabetes Treatment

GLP-1 Drugs Obesity Management GLP-1 Agonists Semaglutide Mounjaro Weight Management Obesity Treatment Type 2 Diabetes GLP-1 Receptor Agonists Weight Loss Medications Insulin Therapy Metformin Ozempic New Medications Novo Nordisk Drug Pricing Januvia Medication Misuse Sales Performance Weight-loss Drug Weight Loss Injections GLP-1 Therapies Weight Loss Drugs Medication Injectable Drugs GLP-1 RA Medications Clinical Trials Injectable Medications GLP-1 Medications Market Competition

Lilly Posts Blowout Quarter as Global GLP‑1 Push Tests Price‑for‑Volume Strategy

Expanded payer coverage, oral Foundayo filings and positive retatrutide trials put pressure on international launches to convert higher patient volume into sustained revenue.

Lilly and Resilience Announce $750 Million Ohio Expansion for KwikPen and Injectables

Large Observational Studies Link GLP‑1 Drugs to Lower Cancer Rates and Slower Progression

Novo Nordisk Lifts 2026 Outlook as Wegovy Pill Powers Big Q1 Beat

Studies Link GLP-1 Drugs to Lower Addiction and Overdose Risks

Insulet Beats Q3 Targets and Lifts 2025 Outlook on Surging Omnipod Sales

Metformin Linked to Lower Dementia and Mortality Risks in Overweight, Obese Adults